CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-21 | Pang Phillip Chief Medical Officer | Sale | −4,630 | $37.44 | $173K | 109,277 |
| 2021-07-21 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,630 | 43,982 | ||
| 2021-07-19 | SATO VICKI L Director | Sale | −8,811 | $36.74 | $324K | 1,633,325 |
| 2021-07-19 | SATO VICKI L Director | Sale | −6,363 | $37.84 | $241K | 1,626,962 |
| 2021-07-15 | MORE ROBERT J Director | Sale | −11,670 | $35.56 | $415K | 46,029 |
| 2021-07-13 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 101,075 |
| 2021-07-13 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $36.72 | $50K | 99,700 |
| 2021-07-13 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 288,005 | ||
| 2021-07-07 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $5.18 | $26K | 114,277 |
| 2021-07-07 | Pang Phillip Chief Medical Officer | Sale | −3,505 | $40.16 | $141K | 110,772 |
| 2021-07-07 | Pang Phillip Chief Medical Officer | Sale | −1,495 | $40.91 | $61K | 109,277 |
| 2021-07-07 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 57,129 | ||
| 2021-07-01 | MORE ROBERT J Director | Grant or award | +1,671 | $43.53 | $73K | 47,700 |
| 2021-07-01 | MORE ROBERT J Director | Sale | −4,794 | $44.31 | $212K | 64,575 |
| 2021-07-01 | MORE ROBERT J Director | Sale | −5,986 | $45.23 | $271K | 58,589 |
| 2021-07-01 | MORE ROBERT J Director | Sale | −890 | $46.22 | $41K | 57,699 |
| 2021-07-01 | NELSEN ROBERT Director | Other disposition | −1,742,248 | 9,437,175 | ||
| 2021-07-01 | NELSEN ROBERT Director | Other disposition | −2,257,752 | 12,229,488 | ||
| 2021-07-01 | NELSEN ROBERT Director | Other acquisition | +47,897 | 83,825 | ||
| 2021-07-01 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −1,742,248 | 9,437,175 |
Page 38 of 54 · 1,063 trades